Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.57 |
| ▸ | NMUR1 | Q9HB89 | 5/20 | 0.57 |
| ▸ | F2 | P00734 | 4/20 | 0.56 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.54 |
| ▸ | MC4R | P32245 | 1/20 | 0.53 |
| ▸ | CTSL | P07711 | 2/20 | 0.51 |
| ▸ | CTSS | P25774 | 2/20 | 0.51 |
| ▸ | CTSK | P43235 | 2/20 | 0.51 |
| ▸ | CTSH | P09668 | 1/20 | 0.51 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.51 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.50 |
| ▸ | CALCR | P30988 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31096802 | 0.88 | C5AR1 (0.53) | C5AR1OPRM1OPRD1CTSLCTSS | |
| SCHEMBL20764557 | 0.88 | APLNR (0.58) | NMUR2NMUR1C5AR1MC4RCTSL | |
| SCHEMBL29980383 | 0.87 | F2 (0.55) | F2OPRM1OPRD1 | |
| SCHEMBL29980269 | 0.87 | F2 (0.55) | F2OPRM1OPRD1 | |
| SCHEMBL30547344 | 0.86 | EPHA2 (0.55) | NMUR2NMUR1F2C5AR1CTSL | |
| SCHEMBL29519729 | 0.86 | C5AR1 (0.54) | F2C5AR1OPRM1MC4RCTSL | |
| SCHEMBL29638059 | 0.86 | MC4R (0.61) | NMUR2NMUR1F2C5AR1MC4R | |
| SCHEMBL29638066 | 0.86 | MC4R (0.61) | NMUR2NMUR1F2C5AR1MC4R | |
| SCHEMBL30903266 | 0.86 | C5AR1 (0.61) | F2C5AR1MC4RCTSLCTSS | |
| [Val5] - Angiotensin Ii SCHEMBL29551599 | 0.85 | AGTR2 (0.64) | F2C5AR1OPRM1OPRD1EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111939244-B | Pharmaceutical composition for preventing or treating diabetic complications | 阿莫生命科学有限公司 | 2024-08-06 | — | — | CN | disclosed |
| US-11607445-B2 | Pharmaceutical composition for preventing or treating diabetic complications | AMOLIFESCIENCE CO., LTD. (KR) | 2023-03-21 | — | — | US | disclosed |